IMMUNOHISTOCHEMICAL LOCALIZATION OF INTRACELLULAR AND EXTRACELLULAR ASSOCIATED TGF-BETA IN THE SKIN OF PATIENTS WITH SYSTEMIC-SCLEROSIS (SCLERODERMA) AND PRIMARY RAYNAUD PHENOMENON

被引:54
作者
GABRIELLI, A
DILORETO, C
TABORRO, R
CANDELA, M
SAMBO, P
NITTI, C
DANIELI, MG
DELUSTRO, F
DASCH, JR
DANIELI, G
机构
[1] UNIV ANCONA, IST ANAT PATOL, I-60100 ANCONA, ITALY
[2] COLLAGEN CORP, PALO ALTO, CA 94303 USA
[3] CELTRIX LABS, PALO ALTO, CA 94303 USA
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1993年 / 68卷 / 03期
关键词
D O I
10.1006/clin.1993.1136
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have investigated the distribution of TGFβ using antibodies specific for its intracellular and extracellular forms in full-thickness biopsies of patients with SSc, primary Raynaud's phenomenon (PRP), systemic lupus erythematosus (SLE), and from normal subjects. Nine of 11 SSc biopsies demonstrated intracellular TGFβ in endothelial cells while only 6 exhibited extracellular TGFβ. Endothelial cells in skin biopsies of all PRP patients displayed both intracellular and extracellular TGFβ. All other control biopsies were negative. In patients with PRP, some positively staining fibroblasts were found scattered throughout the dermis. Lastly, extracellular TGFβ was localized in the papillary dermis of PRP and SSc biopsies and in all the dermal layers of SLE patients. No significant staining of TGFβ was observed in the endothelial cells, fibroblasts, or in the extracellular matrix of the majority of biopsies from normal subjects. These data suggest that TGFβ may be one of the cytokines involved in the early stages of pathogenesis of SSc, and that endothelial cells in SSc and PRP may be a source and/or a target of TGFβ. © 1993 Academic Press. All rights reserved.
引用
收藏
页码:340 / 349
页数:10
相关论文
共 43 条
[1]   PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC-SCLEROSIS (SCLERODERMA) [J].
不详 .
ARTHRITIS AND RHEUMATISM, 1980, 23 (05) :581-590
[2]  
BARBUL A, 1988, GROWTH FACTORS OTHER
[3]  
CZAJA MJ, 1987, J BIOL CHEM, V262, P13348
[4]  
ELLINGSWORTH LR, 1986, J BIOL CHEM, V261, P2362
[5]   TRANSFORMING GROWTH FACTOR-BETA-1 - HISTOCHEMICAL-LOCALIZATION WITH ANTIBODIES TO DIFFERENT EPITOPES [J].
FLANDERS, KC ;
THOMPSON, NL ;
CISSEL, DS ;
VANOBBERGHENSCHILLING, E ;
BAKER, CC ;
KASS, ME ;
ELLINGSWORTH, LR ;
ROBERTS, AB ;
SPORN, MB .
JOURNAL OF CELL BIOLOGY, 1989, 108 (02) :653-660
[6]   VARIABILITY IN COLLAGEN AND FIBRONECTIN SYNTHESIS BY SCLERODERMA FIBROBLASTS IN PRIMARY CULTURE [J].
FLEISCHMAJER, R ;
PERLISH, JS ;
KRIEG, T ;
TIMPL, R .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1981, 76 (05) :400-403
[7]   EVOLUTION OF PRIMARY RAYNAUDS-PHENOMENON (RAYNAUDS DISEASE) TO CONNECTIVE-TISSUE DISEASE [J].
GERBRACHT, DD ;
STEEN, VD ;
ZIEGLER, GL ;
MEDSGER, TA ;
RODNAN, GP .
ARTHRITIS AND RHEUMATISM, 1985, 28 (01) :87-92
[8]  
GOLDRING MB, 1987, J BIOL CHEM, V262, P16724
[9]   TRANSCRIPTION AND EXPRESSION OF TRANSFORMING GROWTH-FACTOR TYPE-BETA IN THE SKIN OF PROGRESSIVE SYSTEMIC-SCLEROSIS - A MEDIATOR OF FIBROSIS [J].
GRUSCHWITZ, M ;
MULLER, PU ;
SEPP, N ;
HOFER, E ;
FONTANA, A ;
WICK, G .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 94 (02) :197-203
[10]   A PROSPECTIVE-STUDY OF RAYNAUD PHENOMENON AND EARLY CONNECTIVE-TISSUE DISEASE - A 5-YEAR REPORT [J].
HARPER, FE ;
MARICQ, HR ;
TURNER, RE ;
LIDMAN, RW ;
LEROY, EC .
AMERICAN JOURNAL OF MEDICINE, 1982, 72 (06) :883-888